BARDA venture capital program dedicates up to $500M for pandemic preparedness Sponsored Content Provided By Pfizer BARDA venture capital program dedicates up to $500M for pandemic preparedness 360Dx Modern Healthcare Illustration / Getty Images NEW YORK – The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority, or BARDA, has launched a new program to spur development of technologies to combat future pandemics and health emergencies. For the initiative, the BARDA Division of Research, Innovation, and Ventures, or DRIVe, will support the BARDA Ventures program in a partnership with the nonprofit Global Health Investment Corporation. According to a statement from HHS, BARDA Ventures will provide GHIC with a minimum of $50 million over five years, and the potential of up to $500 million over 10 years. In turn, GHIC will launch a global health security fund with matching capital from other investors.